Cancer & Therapeutics

Key Information

  • Award: MSc / PG Diploma
  • Non-lab-based Programme
  • Modes of Study: Full Time / Part Time / Full Time - Distance Learning / Part Time - Distance Learning
  • Programme Director: Dr Andrejs Braun
  • Start Date: September 2022
  • Application Deadline: 31 July 2022

For more information and to apply, please visit the Queen Mary University of London website:

This programme is designed to provide students with a clear understanding of the scientific principles underlying the field of cancer therapeutics and the development, evaluation and implementation of new treatments. By the end of the course, in addition to expertise covering the full arsenal of cancer therapeutics, you will be equipped with a thorough knowledge of cancer biology and pathology, research methodologies, drug development, and regulatory issues.

Students will be provided with a firm grounding in the use and evaluation of cancer therapies, which will enhance your career prospects in many areas of cancer research, early phase clinical trials, Allied Health Professions and the pharmaceutical industry.

Compulsory modules

Cancer Biology
Cancer Pharmacology
Molecular Diagnostics and Therapeutics
Research Methods
Clinical Cancer Treatment
Drug Development
Cancer Prevention and Screening
Molecular Targeted Therapies and Immunotherapy for Blood Cancers

Optional modules

Pathology of Cancer & Imaging
Paediatric and Adolescent Oncology
Genomic Approaches to Cancer

Students will choose 15 credits of optional modules - this is likely to be either one 15 credit module or two 7.5 credit modules, depending on the programme structure. For more detailed module information, visit the module details page.

Full Time

Semester 1: September - December (45 or 52.5 credits taught modules)
Semester 2: January - March (75 or 67.5 credits taught modules)
Semester 3: May - August (60 credit Dissertation, MSc only)

Part Time

Year 1

Semester 1: September - December (30 or 37.5 credits taught modules)
Semester 2: January - March (30 or 22.5 credits taught modules)

Year 2

Semester 1: September - December (15 or 22.5 credits taught modules)
Semester 2: January - March (45 or 37.5 credits taught modules)
Semester 3: May - August (60 credit Dissertation, MSc only)


Semester 1: January      Semester 2: March/April       Semester 3: August resits

Each 15 credit module involves approximately 30 hours contact time and 120 hours of self-study.

Each 7.5 credit module involves approximately 15 hours contact time and 60 hours of self-study.

The Dissertation is carried out full time over 12 weeks with regular supervision from one of the Institute’s Research Centres. There may be some flexibility to arrange part-time dissertations for part-time students who are unable to commit to completing this full time. These are arranged on a case-by-case basis in consultation with the Programme Director.

Modes of study
Award and structure

MSc: 120 taught credits + 60 credit Dissertation
PG Diploma: 120 taught credits

A variety of study options are available, these include Full Time (1 year) and Part Time (2 years), on-site or by Distance Learning.

Distance Learning

Distance learning is delivered via the University’s online learning platform - QMplus. Onsite lectures are recorded and made available to Distance Learning students, together with copies of the slides and other supporting teaching materials.
Dissertations will be supervised by a Barts Cancer Institute researcher and supervision meetings will be conducted by telephone or by Skype.


Posters and oral presentations will be delivered via Skype.
Examinations can be at Queen Mary University of London or at an approved local venue (usually a British Council or a local Academic Institution).

Entry Requirements
Academic Entry Requirements
  • A medical degree; or
  • a Bachelor’s degree in a relevant subject from a recognised institution with 2:1 or better. Applicants with a 2:2 and strong supporting evidence will also be considered; or
  • an appropriate professional qualification; or
  • Successful completion of at least 3 years of MBBS studies (including the equivalent of one year of patient-based teaching)*

*Intercalating students must pass exams taken prior to commencing the MSc at first attempt and confirm that the beginning of their following year of MBBS studies start after all assessment for the MSc has been completed.

For more information on intercalated degrees please see here.

For international equivalencies please see the QMUL International Office.

English Language Requirements

Applicants for whom English is not a first language will also require a minimum IELTS score of 7.0 (with 6.5 in writing) or equivalent unless your undergraduate degree was studied in English. For more information on English language requirements, and acceptable qualifications, please visit the Queen Mary English Language Requirements webpage.

How to Apply

All applications must be completed online.

As part of your application you will be required to provide the following documents:

  • Personal Statement
  • CV
  • 2 references (at least one of these must be an academic reference)
  • Copies of degree transcripts
  • English language results and certificate (if applicable)
Intercalating Applicants

Intercalating students must also apply via the Intercalated Degrees Admissions team. Please visit the Queen Mary website for more detailed information about the application process.

Fees & Funding
Full-time study - September 2022 | 1 year
Part-time study - September 2022 | 2 years

Note that fees may be subject to an increase on an annual basis - see details on our tuition fees page.

Funding and scholarships

Numerous funding options are available to Postgraduate students. For more information, visit the Queen Mary Funding a Masters webpage.


Due to receiving large volumes of successful applications, it is our department policy to request a deposit of £2000 from overseas students and £1000 from home/EU students in order to secure your place on the course. This will be payable on acceptance of an offer.

Career Prospects

Career pathways include:

  • Clinical trials
  • Allied Health Professions
  • Pharmaceutical Industry
  • Academia
  • Medicine

Each year we retain a proportion of our graduates within the Institute as PhD students, research assistants or clinical trials co-ordinators.

Find out about the types of projects available

For most of our MSc students, the research project / dissertation is the most exciting part of the programme. Find out more about the research within each of our Centres and the kinds of projects on offer as part of the MSc Programme...

Find out more about studying at BCI

Click below to hear from some of our former and current MSc students and get a feel for what it is like to study at the BCI.

Eric, MSc Cancer & Therapeutics Alumnus

"I enjoyed the interaction between students and lecturers as well as the support provided by the teaching office to international students. Lecturers were always available for students whenever they needed them. I enjoyed the clarity of the courses, which gave us the full package needed for our different career aspirations, be it in clinics, research, industry, and many others. I enjoyed the cultural and professional diversity among students, where we could share our different experiences and learn from each other at the same time."

Read Eric's full alumni profile

Sasi, MSc Cancer & Therapeutics Alumnus

"My mentors Professor Richard Grose, Dr Tony Ford, Professor Jude Fitzgibbon were exceptionally dedicated to the welfare of students. The faculty at Queen Mary are highly intellectual and the programme is brilliantly designed. It starts with basic cancer biology, pharmacology and rapidly delves into how the basic science is useful in designing therapeutics for cancer patients."

Read Sasi's full alumni profile

Connect with us

Follow our social media pages for the latest news and updates

© 2013 ~ 2022 Cancer Research UK Barts Centre